ES2180161T3 - Glicosaminoglicanos con alta actividad antitrombotica in vitro. - Google Patents

Glicosaminoglicanos con alta actividad antitrombotica in vitro.

Info

Publication number
ES2180161T3
ES2180161T3 ES98917065T ES98917065T ES2180161T3 ES 2180161 T3 ES2180161 T3 ES 2180161T3 ES 98917065 T ES98917065 T ES 98917065T ES 98917065 T ES98917065 T ES 98917065T ES 2180161 T3 ES2180161 T3 ES 2180161T3
Authority
ES
Spain
Prior art keywords
vitro
glicosaminoglicanos
antitrombotica
high activity
supersulphated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98917065T
Other languages
English (en)
Inventor
Benito Casu
Annamaria Naggi
Giangiacomo Torri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inalco SpA
Original Assignee
Inalco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inalco SpA filed Critical Inalco SpA
Application granted granted Critical
Publication of ES2180161T3 publication Critical patent/ES2180161T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Glicosaminoglicanos con alta actividad antitrombótica in vitro, obtenidos a partir de diversos tipos de glicosaminoglicanos supersulfatados mediante la preparación de la sal de una base orgánica del glicosaminoglicano supersulfatado de partida, mediante la desulfatación solvolítica parcial de la citada sal y la N- resulfatación del citado producto parcialmente desulfurado.
ES98917065T 1997-03-24 1998-03-24 Glicosaminoglicanos con alta actividad antitrombotica in vitro. Expired - Lifetime ES2180161T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI000678A IT1290814B1 (it) 1997-03-24 1997-03-24 Glicosaminoglicani aventi elevata attivita' antitrombotica

Publications (1)

Publication Number Publication Date
ES2180161T3 true ES2180161T3 (es) 2003-02-01

Family

ID=11376585

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98917065T Expired - Lifetime ES2180161T3 (es) 1997-03-24 1998-03-24 Glicosaminoglicanos con alta actividad antitrombotica in vitro.

Country Status (12)

Country Link
US (1) US6197943B1 (es)
EP (1) EP0970130B1 (es)
JP (1) JP2001518133A (es)
KR (1) KR20000075663A (es)
AT (1) ATE220410T1 (es)
AU (1) AU7040598A (es)
CA (1) CA2285383C (es)
DE (1) DE69806468T2 (es)
DK (1) DK0970130T3 (es)
ES (1) ES2180161T3 (es)
IT (1) IT1290814B1 (es)
WO (1) WO1998042754A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2161615B1 (es) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.
US6977248B1 (en) * 1999-08-25 2005-12-20 Massachusetts Institute Of Technology Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry
US20020062019A1 (en) * 2000-03-30 2002-05-23 Pasqua Oreste Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
IT1318432B1 (it) * 2000-03-30 2003-08-25 Inalco Spa Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
US8227449B2 (en) * 2000-03-30 2012-07-24 Glycores 2000 S.R.L. Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
JP2002080371A (ja) * 2000-06-23 2002-03-19 Seikagaku Kogyo Co Ltd プラスミノーゲンアクチベーター活性促進剤
US6969705B2 (en) * 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
ITMI20010397A1 (it) * 2001-02-27 2002-08-27 Giorgio Zoppetti Derivati altamente n,o-solfatati del polisaccaride k5 e loro preparazione
ITMI20011633A1 (it) * 2001-07-27 2003-01-27 San Raffaele Centro Fond Uso di polisaccaridi batterici supersolfatati inibitori dell'hiv
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
CN1675249A (zh) 2002-06-18 2005-09-28 格利考斯2000有限公司 N－酰基－(表)k5－胺－o－硫酸盐衍生物及其产品的制备方法
US20120253029A1 (en) 2002-06-18 2012-10-04 Pasqua Anna Oreste Process for the preparation of highly o-sulfated epimerized derivatives of k5 polysaccharide and intermediates therein
US20040171819A1 (en) * 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US7956046B2 (en) * 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
ITMI20031618A1 (it) * 2003-08-06 2005-02-07 Inalco Spa Derivati polisaccaridici dotati di alta attivita'
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
AU2008100725B4 (en) * 2008-07-04 2008-10-02 Parnell Technologies Pty Ltd A sulfated polysaccharide compound for clinical use
WO2011090948A1 (en) * 2010-01-19 2011-07-28 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
BR112023022331A2 (pt) 2021-05-12 2023-12-26 Nexeos Diagnostics Inc Métodos de fabricação de um composto de heparina de alto peso molecular

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281108A (en) * 1980-01-28 1981-07-28 Hepar Industries, Inc. Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
FR2538404B1 (es) * 1982-12-28 1985-08-23 Anic Spa
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
GB8519416D0 (en) * 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
EP0333243A3 (en) * 1988-03-10 1989-09-27 Akzo N.V. Sulphated k5 antigen and sulphated k5 antigen fragments
IT1217458B (it) * 1988-05-02 1990-03-22 Crinos Ind Farmacoriologica S Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche
IT1237518B (it) * 1989-11-24 1993-06-08 Renato Conti Eparine supersolfatate
JPH04202401A (ja) * 1990-11-30 1992-07-23 Terumo Corp ヘパリン誘導体の製造法
FR2669932B1 (fr) * 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
FR2704861B1 (fr) * 1993-05-07 1995-07-28 Sanofi Elf Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
ITMI970678A1 (it) 1998-09-24
WO1998042754A2 (en) 1998-10-01
EP0970130B1 (en) 2002-07-10
DE69806468T2 (de) 2003-02-27
EP0970130A2 (en) 2000-01-12
WO1998042754A3 (en) 1998-12-23
DK0970130T3 (da) 2002-11-04
AU7040598A (en) 1998-10-20
DE69806468D1 (de) 2002-08-14
JP2001518133A (ja) 2001-10-09
US6197943B1 (en) 2001-03-06
KR20000075663A (ko) 2000-12-26
CA2285383C (en) 2006-09-26
ATE220410T1 (de) 2002-07-15
CA2285383A1 (en) 1998-10-01
IT1290814B1 (it) 1998-12-11

Similar Documents

Publication Publication Date Title
ES2180161T3 (es) Glicosaminoglicanos con alta actividad antitrombotica in vitro.
AU3310595A (en) Compositions and methods for identifying biologically active molecules
ATE133181T1 (de) Dehydrodidemnin b
ATE397005T1 (de) Sialyl-lewisa und sialyl-lewisx epitope analoge
ES2124668B1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
CO4520232A1 (es) Conjugados de interferon-polimero y proceso para preparar el mismo
ES2126896T3 (es) Dispositivos mejorados de soporte de tejidos biologicos.
AR040873A2 (es) Un metodo para mantener la actividad catalitica de un tamiz molecular de silicoaluminofosfato y un tamiz molecular de silicoaluminofosfato activado
BR9910251A (pt) Estimulação hematopoiética
SE9800853D0 (sv) Intraocular lens
IT1316986B1 (it) Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
AU5061999A (en) Slow release formulations comprising anionic polysaccharide
MX9700885A (es) Nuevas heteroariloxazolidinonas.
ES2067854T3 (es) Polisulfato de derivado de ciclodextrina y procedimiento para preparar el mismo.
HUT63374A (en) Process for producing new benzoic acid derivatives having cardiovascular activity and pharmaceutical compositions comprising such active ingredient
AU2307695A (en) High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base
CA95616S (en) Tanned hide
ATE168152T1 (de) Bauteilsatz zur herstellung eines wurzelraumschutzes
AU6110394A (en) Alteromonas-type bacteria, polysaccharides produced by said bacteria, ose contained in said polysaccharides and applications
ES2098263T3 (es) 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos.
BR9606955A (pt) Heterocicloalquenos substituísos
DE4092406A1 (es)
DE69004808D1 (de) Antibiotikum N-Acetylbenanomicin B, dessen Herstellung und Verwendung.
NO980175L (no) Anvendelse av kationiske biopolymerer for å fremstille antiflassmidler